Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
7,989,235
-
Total 13F shares
-
646,356
-
Share change
-
+636,400
-
Total reported value
-
$3,800,574
-
Price per share
-
$5.88
-
Number of holders
-
10
-
Value change
-
+$3,742,033
-
Number of buys
-
9
Institutional Holders of Traws Pharma, Inc. - Common (TRAW) as of Q3 2024
As of 30 Sep 2024,
Traws Pharma, Inc. - Common (TRAW) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
646,356 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, Tower Research Capital LLC (TRC), Vermillion & White Wealth Management Group, LLC, GROUP ONE TRADING LLC, and Pacific Capital Wealth Advisors, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.